Clinical Outcomes of RTOG 9310 Protocol for Primary Central Nervous System Lymphoma: Single-Center Experience with 87 Patients

The Radiation Therapy Oncology Group (RTOG) 9310 protocol clinical trial established high-dose methotrexate (HDMTX) as the standard for primary central nervous system lymphoma (PCNSL). We aimed to investigate the RTOG 9310 protocol’s PCNSL outcomes by examining progression-free survival (PFS) and ov...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Jinuk, Kim, Tae Gyu, Lee, Hyoun Wook, Kim, Seok Hyun, Park, Ji Eun, Lee, Moonok, Kim, Young Zoon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8628744/
https://www.ncbi.nlm.nih.gov/pubmed/34898570
http://dx.doi.org/10.3390/curroncol28060393

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8628744/
https://www.ncbi.nlm.nih.gov/pubmed/34898570
http://dx.doi.org/10.3390/curroncol28060393

Ejemplares similares